ALENURA Trademark

Trademark Overview

On Monday, February 1, 2021, a trademark application was filed for ALENURA with the United States Patent and Trademark Office. The USPTO has given the ALENURA trademark a serial number of 90502530. The federal status of this trademark filing is REGISTERED as of Tuesday, February 4, 2025. This trademark is owned by Urigen Pharmaceuticals Inc.. The ALENURA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of urological ailments; Pharmaceutical preparations for the treatment of interstitial cystitis and bladder pain syndrome (IC/BPS)
alenura

General Information

Serial Number90502530
Word MarkALENURA
Filing DateMonday, February 1, 2021
Status700 - REGISTERED
Status DateTuesday, February 4, 2025
Registration Number7680576
Registration DateTuesday, February 4, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of urological ailments; Pharmaceutical preparations for the treatment of interstitial cystitis and bladder pain syndrome (IC/BPS)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 4, 2021
Primary Code005
First Use Anywhere DateWednesday, November 20, 2024
First Use In Commerce DateWednesday, November 20, 2024

Trademark Owner History

Party NameUrigen Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBound Brook, NJ 08805
Party NameUrigen Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBound Brook, NJ 08805
Party NameUrigen Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBound Brook, NJ 08805

Trademark Events

Event DateEvent Description
Friday, August 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 4, 2021NEW APPLICATION ENTERED
Tuesday, May 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 20, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 27, 2022SOU EXTENSION 1 FILED
Friday, May 27, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 2 FILED
Wednesday, November 30, 2022SOU EXTENSION 2 GRANTED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, May 30, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, May 30, 2023SOU EXTENSION 3 FILED
Tuesday, June 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 29, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, June 29, 2023SOU EXTENSION 3 GRANTED
Friday, June 30, 2023CORRECTED NOA E-MAILED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 4 FILED
Thursday, November 30, 2023SOU EXTENSION 4 GRANTED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 5 FILED
Wednesday, May 29, 2024SOU EXTENSION 5 GRANTED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2024USE AMENDMENT FILED
Tuesday, November 26, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, December 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, January 17, 2025HIDDEN SENSITIVE CONTENT
Thursday, January 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 16, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 4, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 4, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

alenura pharmaceutical treatment preparations pain syndrome bladder ailments urological interstitial cystitis